Entries by Karl Moran

Highlights of the Microbiome Drug Development Summit 2018 in Boston

Development and commercialization of microbiome-based therapeutics was the focus of a recent event in Boston (USA): the Microbiome Drug Development Summit 2018, organized by Hanson Wade. The Microbiome Insights team was in attendance – and here we share some of the highlights from this exciting event: DAY 1 Jennifer Wortman, Senior Director, Bioinformatics, Seres Therapeutics…

Microbiome Insights hosts students for educational laboratory tour

JUNE 15, 2018 — Microbiome Insights was pleased to welcome an enthusiastic group of post-secondary students from Vancouver’s Alexander College this week for a laboratory tour and presentation. During the visit team member Ben Tantika, Senior Next-generation Sequencing Technician, described the cellular and molecular biology techniques used in research labs to answer scientific questions. The…

Banff Keystone Symposia on Gut Microbiota: Day Two Summary

March 6, 2018 marked the second day of the joint Keystone Symposia in Banff, Canada: (1) “Manipulation of the Gut Microbiota for Metabolic Health” and (2) “Microbiome, Host Resistance and Disease”. Morning sessions were split into two tracks. The first track covered microbiota and metabolic disorders, with two initial talks by François Leulier (Institut de…

Banff Keystone Symposia on Gut Microbiota: Day One Summary

Gut microbiota researchers from across the globe gathered in Banff, Canada for two joint conferences: (1) “Manipulation of the Gut Microbiota for Metabolic Health” and (2) “Microbiome, Host Resistance and Disease”. On day one of the conference—March 5, 2018—all sessions were held concurrently. For several human diseases, observed differences in gut microbiota composition between disease…

PRESS RELEASE: Exploring the ‘second genome’ for new insights: Genome BC invests in local microbiome startup

DECEMBER 6, 2017 – As part of its Industry Innovation Program (I² Fund), Genome BC is investing CAD $750,000 in a local microbiome testing company—Vancouver-based Microbiome Insights (MBI), which provides next-generation-sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry. The new funding adds to the company’s recent round of equity financing,…